RIO DE JANEIRO, BRAZIL - A Peruvian woman age 54, apparently healthy, who had volunteered to participate in the Chinese giant Sinopharm's vaccine trials against the novel coronavirus, died of Covid-19, reported Tuesday the Health Authority in charge of the trial in Lima.
"We regret to announce that one of our volunteers died as a result of Covid-19 pneumonia," said the Peruvian Cayetano Heredia University, in charge of the clinical trials of Sinopharm's vaccine.
The university added that it had communicated the case to the study’s safety committee and to regulatory authorities for an investigation to . . .